• Coordinated clinical studies (feasibility study, methodology)
• Operational monitoring of projects, dashboards and monitoring of charts
• Managed of cross-functional teams and third-party vendors
• Coordinated setting up and logistical follow-up of the clinical studies
• Managed the budgets of the various clinical studies
• Prepared and delivered study-related updates, dashboards, and reports to study teams, and sponsors/vendors/partners
• Ensure regulatory submission in several countries
• Drafting and updating the different documents according to the MDR requirement (CER, PMS, CDP, IFU...)
• Designed and developed pre-clinical and clinical studies for a new medical device to obtain CE marking
• Initiate PMCF studies for different medical devices
• Medical referee for 3 medical devices (MD)
• Managed the translation of all company medical device IFUs into 22 languages
• Maintained study-related essential documents and ensured compliance with regulatory requirements
• Conducted medico-scientific of clinical studies in nutrition
• Feasibility study in collaboration with the different departments (Biostatistics, data management, legal department, scientists….)
• Selection and collaboration with CROs to carry out certain study tasks
• Estimation and management of the study budget
• Designed and developed protocols in the field of digital dietary assessment Tool
• Collaborated with clinical operational teams and the different departments to carry out the studies
• Collaborated effectively with internal and external stakeholders, communicated project status, escalated issues, and troubleshooted
• Publication of a scientific review (a viewpoint) (in publications list)
• Conducting bibliographic research to develop the scientific context and essential elements of a protocol
• Conducted medico-scientific and follow-up of clinical studies
• Communication with Key Opinion Leaders to develop the study design
• Designed and developed protocols and all the essential documents of a clinical study (ICF, e-CRF, reports…)
• Collaborated with clinical operational teams and followed the mandates of the regulatory authorities.
• Collected, analyzed and summarized clinical data for submission to regulatory agencies
• Responsible for oversight of identification and selection of investigator site
• Foretasted and budgeted for all projects and clinical studie
• Designed and developed protocols and amendments in clinical studies with quality and respect for procedures
• Conducted medico-scientific follow-up of clinical studies in dialectology
• Collaborated on medical-scientific reports of clinical study
• Managed various transversal processes of the clinical projects (BIC, regulatory process)
• Coordinated all clinical studies of the center: feasibility studies, methodologies, dashboards and chart monitoring, Initiate telemedicine studies
• Developed protocols, CRF, patient information notes and regulatory submissions (CPP, ANSM, CNIL)
• Designed and managed subject databases
• Conducted logistical follow-up of the clinical studies with the different representatives of the clinical research (the CROs, the investigator centers, the regulatory authorities, CRA)
• Managed the budgets of the various clinical studies
• Conducted training and ensured proper resource allocation for study teams
• Coordinated clinical studies (feasibility study, methodology),
• Operational monitoring of projects, dashboards and monitoring of charts
• Managed a team of CRA
• Coordinated logistical follow-up of the clinical studies
• Managed the budgets of the various clinical studies
• Designed and managed databases.
• Assumed overall responsibility for negotiation of development and management of various clinical trials
• Prepared, organized and developed specifications for clinical research and protocol tools.
• Wrote CRF (case report forms).
• Completed visits implementation, monitoring and closing centers.
ENGLISH
FRENCH
ARABIC
ENNOV
CLINICAL
VEEVA
MICROSOFT
ONCOLOGY, CARDIOLOGY, IMMUNOLOGY, DERMATOLOGY, UROLOGY, HEMATOLOGY
§ Khazen W, Jeanne J, Demaretz L, Schäfer F, Fagherazzi G. Rethinking the use of mobile applications for dietary assessment in medical research: a viewpoint. J Med Internet Res 2020;22(6):e15619
§ FRACHET B, W.Khazen: Les jeunes et la musique: quels dangers auditifs. Le Figaro ,13 octobre 2015.
§ M'bika JP, Khazen W, Achour A, Chany C. Expression of sarcolectin in the human pituitary gland and amniotic fluid. Biochimie. Aug 2010; 92:1085-108.
§ Wael Khazen, Emilie Distel, Martine Collinet, Jean-Pierre M'Bika, Charles Chany, Ammar Achour, Chantal Benelli and Claude Forest. Acute and selective inhibition of adipocyte glyceroneogenesis and cytosolic Phosphoenol pyruvate carboxykinase by interferon gamma. Endocrinology. Aug2007;148:4007-4014.
§ Wael Khazen, Jean-Pierre M'Bika, Martine Collinet, Charles Chany, Ammar Achour and Claude Forest. Differentiation-dependent expression of interferon gamma in 3T3-F442A adipocytes. Biochimie. May 2007; 89:669-675.
§ Jean Pierre M’Bika-Binzangi, Ammar Achour, Wael Khazen, Magalli Gillibert, Charles Chany. Effets of sarcolectin (SCL) on human peripheral blood mononuclear cells. Biochimie. Jun 2006; 88:683-92.
§ Wael Khazen, Jean-Pierre M’Bika, Celine Tomkiewicz, Chantal Benelli, Charles Chany, AmmarAchour, Claude Forest. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS letters, Oct 2005 ; 25:5631-5634.
§ Joan Tordjman, Wael Khazen, Bénédicte Antoine, Geneviève Chauvet, Joëlle Quette, Françoise Fouque, Elmus G Beale, Chantal Benelli, Claude Forest. Regulation of glyceroneogenesis and Phosphoenol pyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes. Biochimie. Dec2003; 85:1213-1218.